Show simple item record

dc.contributor.authorWeinbren, Michael
dc.date.accessioned2022-11-01T15:27:46Z
dc.date.available2022-11-01T15:27:46Z
dc.date.issued2022-05
dc.identifier.citationMoira A. Mugglestone et al. (2022) ‘Presymptomatic, asymptomatic and post-symptomatic transmission of SARS-CoV-2: joint British Infection Association (BIA), Healthcare Infection Society (HIS), Infection Prevention Society (IPS) and Royal College of Pathologists (RCPath) guidance’, BMC Infectious Diseases, 22(1), pp. 1–15en_US
dc.identifier.urihttp://hdl.handle.net/20.500.12904/15928
dc.description.abstractThis is the second of two guidance articles produced by the British Infection Association (BIA), the Healthcare Infection Society (HIS), the Infection Prevention Society (IPS) and the Royal College of Pathologists (RCPath). Both articles refer to the pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Using evidence that emerged during the first wave of the pandemic, the articles summarise aspects of the transmission dynamics of SARS-CoV-2 and provide guidance on how to reduce the risk of transmission. This article focuses on the risks of presymptomatic, asymptomatic and post-symptomatic SARS-CoV-2 transmission, allowing healthcare workers and the public to understand how transmission occurs and to take action to protect themselves and others. The guidance recognises further waves of the pandemic, the possibility of reinfection, the emergence of new variants of the virus and ongoing immunisation programmes.
dc.description.urihttps://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-022-07440-0en_US
dc.publisherBMC Infectious Diseasesen_US
dc.subjectAsymptomaticen_US
dc.subjectCOVID-19en_US
dc.subjectGuidelineen_US
dc.subjectInfectionen_US
dc.subjectPost-symptomaticen_US
dc.subjectPresymptomaticen_US
dc.subjectSARS-CoV-2en_US
dc.subjectTransmissionen_US
dc.titlePresymptomatic, asymptomatic and post-symptomatic transmission of SARS-CoV-2: joint British Infection Association (BIA), Healthcare Infection Society (HIS), Infection Prevention Society (IPS) and Royal College of Pathologists (RCPath) guidanceen_US
dc.typeArticleen_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US
rioxxterms.versionNAen_US
rioxxterms.versionofrecord10.1186/s12879-022-07440-0en_US
rioxxterms.typeJournal Article/Reviewen_US
refterms.dateFOA2022-11-01T15:27:47Z
refterms.panelUnspecifieden_US
html.description.abstractThis is the second of two guidance articles produced by the British Infection Association (BIA), the Healthcare Infection Society (HIS), the Infection Prevention Society (IPS) and the Royal College of Pathologists (RCPath). Both articles refer to the pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Using evidence that emerged during the first wave of the pandemic, the articles summarise aspects of the transmission dynamics of SARS-CoV-2 and provide guidance on how to reduce the risk of transmission. This article focuses on the risks of presymptomatic, asymptomatic and post-symptomatic SARS-CoV-2 transmission, allowing healthcare workers and the public to understand how transmission occurs and to take action to protect themselves and others. The guidance recognises further waves of the pandemic, the possibility of reinfection, the emergence of new variants of the virus and ongoing immunisation programmes.en_US
rioxxterms.funder.project94a427429a5bcfef7dd04c33360d80cden_US


Files in this item

Thumbnail
Name:
Presymptomatic, asymptomatic and ...
Size:
971.7Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record